GUEST COLUMNISTS

• Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models

  Let's delve into the key pitfalls to avoid when working with a CDMO and the integrated execution model that solves or mitigates these pitfalls before they occur.

• The Future Of Continuous Is Integrated Manufacturing: The 4 Misconceptions About A Lean Process

  Pharmaceutical continuous manufacturing is an enabler of better manufacturing, but only when implemented with intention.

• CDMO Selection: Start With The Relationship, Not The RFP

  Friction often comes from unspoken expectations. Before production begins, treat the combined sponsor-CDMO group as one extended team and intentionally make “how we work together” visible.

• Why FAT Should Confirm Alignment, Not Reveal Its Absence

  In many aseptic fill/finish projects, the factory acceptance test (FAT) has become the first true integration test of the entire project. That is a problem. Here's how to flip that mindset.

• What Reliance, Annex 1, And AI Mean For The Future Of GMP

  EMA’s Brendan Cuddy explains how regulators are adapting oversight to global supply chains, new technologies, and growing operational complexity.

• Applying Contamination Control By Design: A Practical Guide For CDMOs

  This article addresses the three contamination control challenges that are specific to the CDMO environment, provides five practical steps any organization can act on now, and more.

• Rethinking CQV In A Digital, Agile Manufacturing Landscape

  While commissioning, qualification, and validation (CQV) remains foundational, the way it is planned and executed must evolve to keep pace with modern manufacturing realities.

• Will FDA's One-Day Inspection Pilot Stand The Test Of Time?

  FDA's complementary pilot could help weed through a persistent examination backlog, but uncertainty and upheaval in leadership at the top puts its future in question.